FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym Active Entire term case insensitive SNOMED CT core module
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442103019 2 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    2 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    2 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae antigens (medicinal product) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Vaccine product containing only Neisseria meningitidis serogroup A and C antigens (medicinal product) Count of active ingredient False 2 Inferred relationship Existential restriction modifier
    Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (medicinal product) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Vaccine product containing only Haemophilus influenzae type b and Hepatitis B virus antigens (medicinal product) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram and ritonavir 100 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only atazanavir and ritonavir in oral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only atazanavir and ritonavir (medicinal product) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (medicinal product) Count of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely pyrantel (as pyrantel pamoate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only cedazuridine and decitabine (medicinal product) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only cedazuridine and decitabine in oral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cedazuridine 100 milligram and decitabine 35 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ledipasvir 90 milligram and sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ledipasvir 45 milligram and sofosbuvir 200 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely glecaprevir 100 milligram and pibrentasvir 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely bisacodyl 2 milligram/1 milliliter conventional release rectal suspension (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely baricitinib 2 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely wool alcohol 2 milligram/1 gram conventional release eye ointment (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Helium + Oxygen Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Nitrous oxide + Oxygen Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Oxygen + Carbon dioxide Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only nitrous oxide and oxygen in conventional release gas for inhalation (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only helium and oxygen in conventional release gas for inhalation (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only carbon dioxide and oxygen in conventional release gas for inhalation (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely trametinib (as trametinib dimethyl sulfoxide) 2 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely nitrous oxide 0.5 milliliter/1 milliliter and oxygen 0.5 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely air 0.95 milliliter/1 milliliter and carbon dioxide 0.05 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Carbon dioxide + Air Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only air and carbon dioxide in conventional release gas for inhalation (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely carbon dioxide 0.2 milliliter/1 milliliter and oxygen 0.8 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely carbon dioxide 0.1 milliliter/1 milliliter and oxygen 0.9 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely carbon dioxide 0.05 milliliter/1 milliliter and oxygen 0.95 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely helium 0.79 milliliter/1 milliliter and oxygen 0.21 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely arsenic trioxide 2 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing only insulin lispro and insulin lispro protamine in parenteral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only human isophane insulin and recombinant human regular insulin in parenteral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only human isophane insulin and recombinant human regular insulin (medicinal product) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only dimeticone and loperamide in oral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only porcine isophane insulin and porcine regular insulin in parenteral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only porcine isophane insulin and porcine regular insulin (medicinal product) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cyclizine tartrate 50 milligram/1 milliliter and morphine tartrate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only cyclizine and morphine in parenteral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cyclizine tartrate 50 milligram/1 milliliter and morphine tartrate 15 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C and Y antigens (medicinal product) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely chlordiazepoxide hydrochloride 5 milligram and clidinium bromide 2.5 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amiloride hydrochloride 5 milligram and bumetanide 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amiloride hydrochloride 10 milligram and furosemide 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ephedrine sulfate 15 milligram and theophylline 120 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and telmisartan 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely epinephrine 2 milligram/1 milliliter and guanethidine monosulfate 10 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely clioquinol 10 milligram/1 milliliter and flumetasone pivalate 200 microgram/1 milliliter conventional release ear drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely adapalene 1 milligram/1 gram and benzoyl peroxide 25 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amoxicillin 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear or eye or nose drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lopinavir 100 milligram and ritonavir 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ampicillin (as ampicillin sodium) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely felodipine 2.5 milligram and ramipril 2.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone 10 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ferrous fumarate 322 milligram and folic acid 350 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amitriptyline 10 milligram and perphenazine 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lauromacrogol 30 milligram/1 gram and urea 50 milligram/1 gram conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely enalapril 20 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely tegafur 100 milligram and uracil 224 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metoclopramide hydrochloride 5 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ezetimibe 10 milligram and simvastatin 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely clorquinaldol 30 milligram/1 gram and hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely econazole nitrate 10 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lactic acid 40 milligram/1 gram and salicylic acid 120 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely colloid sulfur 80 milligram/1 gram and resorcinol 20 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely atenolol 100 milligram and chlortalidone 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely diclofenac sodium 50 milligram and misoprostol 200 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely mineral oil 500 milligram/1 gram and white petrolatum 500 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ibuprofen 200 milligram and pseudoephedrine 30 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely domiphen bromide 500 microgram and lidocaine hydrochloride 5 milligram/1 each conventional release oromucosal lozenge Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely bendroflumethiazide 5 milligram and nadolol 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely alverine citrate 5 milligram/1 gram and Sterculia gum 620 milligram/1 gram conventional release oral granules Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely acebutolol 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydroflumethiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier

    Start Previous Page 24 of 35 Next End

    This concept is not in any reference sets

    Back to Start